Perrigo to Buy Elan for $8.6B to Get Irish Tax Base

Perrigo to Buy Elan for $8.6B to Get Irish Tax Base Play

July 29 (Bloomberg) -- Perrigo, a U.S. maker of over-the-counter medicines, agreed to buy Irish drug company Elan for $8.6 billion, gaining a low-tax base for international expansion. Olivia Sterns reports on Bloomberg Television's "Taking Stock." (Source: Bloomberg)

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

blog comments powered by Disqus